Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin

Virus Research

Volumn 98, Issue 1, 2003, Pages 1-15

  Winslow, Barbara J ^a,b   Cochran, Mark D ^a   Holzenburg, Andreas ^c,d   Sun, Jingchuan ^c,d   Junker, David E ^a   Collisson, Ellen W ^b  

^a Schering Plough Anim Hlth Corp   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Department of Electrical and Computer Engineering   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Feline leukemia virus; Retrovirus like particles (VLP); Swinepox virus; Vaccine; Viral vector

Indexed keywords

FELINE LEUKEMIA VIRUS VACCINE; GAG PROTEIN; SYNTHETIC DNA; VIRUS ANTIGEN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; ATTENUATION; CAT; CELL LINE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; FELINE LEUKEMIA VIRUS; GENE DELETION; GENE EXPRESSION; KIDNEY CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN FIBROBLAST; SWINE; SWINEPOX VIRUS; VIRION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION;

FELIDAE; FELINE LEUKEMIA VIRUS; FELIS CATUS; MAMMALIA; POXVIRIDAE; SUS SCROFA; SWINEPOX VIRUS; SWINEPOX VIRUS (STRAIN KASZA); UNIDENTIFIED RETROVIRUS;

EID: 0242438617     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2003.08.005     Document Type: Article

References (59)

1. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Osorio F.A., Balinsky C., Kutish G.F., Rock D.L. The genome of swinepox virus. J. Virol. 76(2):2002;783-790.
2. Barcena J., Blasco R. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture. Virology. 243(2):1998;396-405.
3. Bertholet C., Drillien R., Wittek R. One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proc. Natl. Acad. Sci. U.S.A. 82(7):1985;2096-2100.
4. Broder C.C., Earl P.L. Recombinant vaccinia viruses. Design, generation. and isolation. Mol. Biotechnol. 13(3):1999;223-245.
5. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5(12):1985;3403-3409.
6. Christensen N.D., Reed C.A., Cladel N.M., Han R., Kreider J.W. Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papilloma virus. J. Virol. 70(2):1996;960-965.
7. Cochran M.A., Mackett M., Moss B. Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus. Proc. Natl. Acad. Sci. U.S.A. 82(1):1985;19-23.
8. Coyne M.J., Reeves N.C., Rosen D.K. Estimated prevalence of injection-site sarcomas in cats during 1992. J. Am. Vet. Med. Assoc. 210(2):1997;249-251.
9. Datt N.S. Comparative studies of pigpox and vaccinia viruses. J. Comp. Path. 74:1964;62-69.
10. Davison A.J., Moss B. Structure of vaccinia virus early promoters. J. Mol. Biol. 210(4):1989a;749-769.
11. Davison A.J., Moss B. Structure of vaccinia virus late promoters. J. Mol. Biol. 210(4):1989b;771-784.
12. Galea P., le Contel C., Coutton C., Chermann J.C. Rationale for a vaccine using cellular-derived epitope presented by HIV isolates. Vaccine. 17(13/14):1999;1700-1705.
13. Garg S.K., Meyer R.C. Adaptation of swinepox virus to an established cell line. Appl. Microbiol. 23(1):1972;180-182.
14. Gobar G.M., Kass P.H. World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats. J. Am. Vet. Med. Assoc. 220(10):2002;1477-1482.
15. Gomez C.E., Esteban M. Recombinant proteins produced by vaccinia virus vectors can be incorporated within the virion (IMV form) into different compartments. Arch. Virol. 146(5):2001;875-892.
16. Hahn J., Park S.H., Song J.Y., An S.H., Ahn B.Y. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein. J. Virol. Methods. 93(1/2):2001;49-56.
17. Hardy, W.D.J., 1980. Feline leukemia virus diseases. In: Hardy, W.D.F., Essex, M., McClelland, A.J. (Eds.), Feline Leukemia Virus, Elsevier/North Holland, New York, pp. 3-31.
18. Hendrick M.J., Goldschmidt M.H., Shofer F.S., Wang Y.Y., Somlyo A.P. Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum. Cancer Res. 52(19):1992;5391-5394.
19. Hines D.L., Cutting J.A., Dietrich D.L., Walsh J.A. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection. J. Am. Vet. Med. Assoc. 199(10):1991;1428-1430.
20. Hoover E.A., Olsen R.G., Hardy W.D. Jr., Schaller J.P., Mathes L.E. Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J. Natl. Cancer Inst. 57(2):1976;365-369.
21. Hoppert, M.a.A.H., 1998. Electron Microscopy in Microbiology. RMS Microscopy Handbook Series, vol. 43. Bio Scientific Publishers, Oxford, UK.
22. House, J.A., House, C.A., 1992. In: Leman, A.D., Straw, B.E., Mengeling, W.L., D'Allaire, S., Taylor, D.J. (Eds.), Diseases of Swine, seventh ed. Iowa State University Press, Ames, pp. 358-361.
23. Hu S.L., Travis B.M., Garrigues J., Zarling J.M., Sridhar P., Dykers T., Eichberg J.W., Alpers C. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus. Virology. 179(1):1990;321-329.
24. Kass P.H., Barnes W.G. Jr., Spangler W.L., Chomel B.B., Culbertson M.R. Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J. Am. Vet. Med. Assoc. 203(3):1993;396-405.
25. Kasza, L., 1981. Swine pox. In: Leman, A.D., Glock, R.D., Mengeling, W.L., Penny, R.H.C., Scholl, E., Straw, B. (Eds.), Diseases of Swine, fifth ed. Iowa State University Press, Ames, pp. 254-260.
26. Kumar S., Boyle D.B. A poxvirus bidirectional promoter element with early/late and late functions. Virology. 179(1):1990;151-158.
27. Le Tissier P., Stoye J.P., Takeuchi Y., Patience C., Weiss R.A. Two sets of human-tropic pig retrovirus. Nature. 389(6652):1997;681-682.
28. Mackett M., Smith G.L., Moss B. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49(3):1984;857-864.
29. Macy D.W. The potential role and mechanisms of FeLV vaccine-induced neoplasms. Semin. Vet. Med. Surg. (Small Anim.). 10(4):1995;234-237.
30. Macy D.W. Current understanding of vaccination site-associated sarcomas in the cat. J. Feline Med. Surg. 1(1):1999;15-21.
31. Massung R.F., Moyer R.W. The molecular biology of swinepox virus. I. A characterization of the viral DNA. Virology. 180(1):1991;347-354.
32. Matthews. 1982. Classification and nomenclature of viruses. Fourth Report of the International Committee on Taxonomy of Viruses. Intervirology 17(1-3), 1-199.
33. McCabe V.J., Tarpey I., Spibey N. Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein. Vaccine. 20(19-20):2002;2454-2462.
34. McGuigan L.C., Stallard V., Roos J.M., Payne L.G. Recombinant-expressed virus-like particle pseudotypes as an approach to vaccine development. Vaccine. 11(6):1993;675-678.
35. McNiel, E.A., 2001. Vaccine-associated sarcomas in cats: a unique cancer model, Clin. Orthop. (382), 21-27.
36. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. U.S.A. 93(21):1996;11341-11348.
37. Ott D.E., Coren L.V., Kane B.P., Busch L.K., Johnson D.G., Sowder R.C. II, Chertova E.N., Arthur L.O., Henderson L.E. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 70(11):1996;7734-7743.
38. Overbaugh J., Donahue P.R., Quackenbush S.L., Hoover E.A., Mullins J.I. Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science. 239(484):1988;906-910.
39. Paliard X., Liu Y., Wagner R., Wolf H., Baenziger J., Walker C.M. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques. AIDS Res. Hum. Retroviruses. 16(3):2000;273-282.
40. Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. U.S.A. 93(21):1996;11349-11353.
41. Paoletti E., Taylor J., Meignier B., Meric C., Tartaglia J. Highly attenuated poxvirus vectors: NYVAC ALVAC and TROVAC. Dev. Biol. Stand. 84:1995;159-163.
42. Payne L. Polypeptide composition of extracellular enveloped vaccinia virus. J. Virol. 27(1):1978;28-37.
43. Somogyi P., Frazier J., Skinner M.A. Fowlpox virus host range restriction: gene expression DNA replication and morphogenesis in nonpermissive mammalian cells. Virology. 197(1):1993;439-444.
44. Spear G.T., Lurain N.S., Parker C.J., Ghassemi M., Payne G.H., Saifuddin M. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalo virus (HCMV). J. Immunol. 155(9):1995;4376-4381.
45. Stannard L.M., Marais D., Kow D., Dumbell K.R. Evidence for incomplete replication of a penguin poxvirus in cells of mammalian origin. J. Gen. Virol. 79(Pt. 7):1998;1637-1646.
46. Takeuchi Y., Patience C., Magre S., Weiss R.A., Banerjee P.T., Le Tissier P., Stoye J.P. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72(12):1998;9986-9991.
47. Tang Y., Winkler U., Freed E.O., Torrey T.A., Kim W., Li H., Goff S.P., Morse H.C. 3rd Cellular motor protein KIF-4 associates with retroviral Gag. J. Virol. 73(12):1999;10508-10513.
48. Taylor J., Weinberg R., Languet B., Desmettre P., Paoletti E. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine. 6(6):1988;497-503.
49. Taylor J., Trimarchi C., Weinberg R., Languet B., Guillemin F., Desmettre P., Paoletti E. Efficacy studies on a canarypox-rabies recombinant virus. Vaccine. 9(3):1991;190-193.
50. Taylor J., Meignier B., Tartaglia J., Languet B., VanderHoeven J., Franchini G., Trimarchi C., Paoletti E. Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species. Vaccine. 13(6):1995;539-549.
51. Theilen G.H., Kawakami T.G., Rush J.D., Munn R.J. Replication of cat leukemia virus in cell suspension cultures. Nature. 222(193):1969;589-590.
52. Thomsen D.R., Meyer A.L., Post L.E. Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system. J. Gen. Virol. 73(Pt. 7):1992;1819-1824.
53. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76(9):1979;4350-4354.
54. Tripathy D.N. Swinepox virus as a vaccine vector for swine pathogens. Adv. Vet. Med. 41:1999;463-480.
55. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., Rock D.L. Genome of lumpy skin disease virus. J. Virol. 75(15):2001;7122-7130.
56. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Sur J.H., Sandybaev N.T., Kerembekova U.Z., Zaitsev V.L., Kutish G.F., Rock D.L. The genomes of sheeppox and goatpox viruses. J. Virol. 76(12):2002;6054-6061.
57. van der Leek M.L., Feller J.A., Sorensen G., Isaacson W., Adams C.L., Borde D.J., Pfeiffer N., Tran T., Moyer R.W., Gibbs E.P. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec. 134(1):1994;13-18.
58. Venkatesan S., Baroudy B.M., Moss B. Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell. 25(3):1981;805-813.
59. Weir J.P., Moss B. Regulation of expression and nucleotide sequence of a late vaccinia virus gene. J. Virol. 51(3):1984;662-669.